Intracerebroventricular guanine-based purines protect against seizures induced by quinolinic acid in mice.
Acute and chronic administration of the nucleoside guanosine have been shown to prevent quinolinic acid (QA) and alpha-dendrotoxin-induced seizures, as well as to impair memory and anxiety in rats and mice. In this study, we investigated the effect of i.c.v. administration of guanine-based purines (GTP, GDP, GMP, and guanosine) against seizures induced by the NMDA agonist and glutamate releaser quinolinic acid in mice. We also aimed to study the effects of the poorly hydrolysable analogs of GTP (GppNHp and GTPgammaS) and GDP (GDPbetaS) in this seizure model. QA produced seizures in 100% of mice, an effect partially prevented by guanine-based purines. In contrast to GTP (480 nmol), GDP (320-640 nmol), GMP (320-480 nmol) and guanosine (300-400 nmol), the poorly hydrolysable analogs of GTP and GDP did not affect QA-induced seizures. Thus, the protective effects of guanine nucleotides seem to be due to their conversion to guanosine. Altogether, these findings suggest a potential role of guanine-based purines for treating diseases involving glutamatergic excitotoxicity.
Schmidt
André P
AP
Department of Biochemistry, ICBS, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil. apschmidtus@yahoo.com
Avila
Thiago T
TT
Souza
Diogo O
DO
D000818:Animals; D004305:Dose-Response Relationship, Drug; D006150:Guanine Nucleotides / Q000627:therapeutic use*; D007276:Injections, Intraventricular; D008297:Male; D051379:Mice; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D017378:Quinolinic Acid / Q000633:toxicity*; D012640:Seizures / Q000139:chemically induced* / Q000517:prevention & control*
D006150:Guanine Nucleotides; D018696:Neuroprotective Agents; D017378:Quinolinic Acid